NeoGenomics: Q4 Earnings Snapshot

Associated Press Finance
1 min read
0
In this article:

FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $14.3 million in its fourth quarter.

The Fort Myers, Florida-based company said it had a loss of 11 cents per share. Earnings, adjusted for amortization costs and stock option expense, came to 3 cents per share.

The results surpassed Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 1 cent per share.

The operator of cancer-focused testing laboratories posted revenue of $155.6 million in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $152.9 million.

For the year, the company reported a loss of $88 million, or 70 cents per share. Revenue was reported as $591.6 million.

NeoGenomics expects full-year revenue in the range of $650 million to $660 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NEO at https://www.zacks.com/ap/NEO

Advertisement

Recommended Stories